March 22, 2017 11:37 PM ET

Pharmaceuticals

Company Overview of IASO Pharma Inc.

Key Executives for IASO Pharma Inc.

NameBoard RelationshipsTitleAge
Matthew A. Wikler M.D., M.B.A., F.I.D.S.A.1 RelationshipsChief Executive Officer, President and Director66
James Rock M.S. M.B.A.No RelationshipsDirector of New Product Development48

IASO Pharma Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Matthew A. Wikler M.D., M.B.A., F.I.D.S.A. 1 RelationshipsIASO Pharma Inc.66
J. Jay Lobell J.D. 32 RelationshipsParamount BioCapital, Inc.53
View All Board Members

IASO Pharma Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$247.5K
247.5K
327.2K
Bonus$60.0K
60.0K
445.9K
Total Short Term Compensation$307.5K
307.5K
477.6K
Total Value of Options
6.6M
Compensation as of Fiscal Year
IASO Pharma Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Redx Pharma Plc Announces Retirement of Jackson from the Board
March 21, 2017 7:14 PM ET
Oramed Appoints Ronald Law as Chief Strategy Officer
March 21, 2017 12:45 PM ET
Aurora Cannabis Inc. Appoints Neil Belot as Chief Global Business Development Officer
March 21, 2017 11:00 AM ET
Knopp Biosciences Elects Shane Kovacs to Board of Managers
March 21, 2017 10:00 AM ET
Ocular Therapeutix, Inc. Announces Executive Changes
March 20, 2017 8:33 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact IASO Pharma Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.